Light chain (AL) amyloidosis: update on diagnosis and management

Light chain (AL) amyloidosis: update on diagnosis and management

<p>Abstract</p> <p>Light chain (AL) amyloidosis is a plasma cell dyscrasia characterized by the pathologic production of fibrillar proteins comprised of monoclonal light chains which deposit in tissues and cause organ dysfunction. The diagnosis can be challenging, requiring a biops...

Full description

Bibliographic Details
Main Authors:	Rosenzweig Michael, Landau Heather
Format:	Article
Language:	English
Published:	BMC 2011-11-01
Series:	Journal of Hematology & Oncology
Online Access:	http://www.jhoonline.org/content/4/1/47

Similar Items

Retinitis pigmentosa associated with systemic light chain amyloidosis (AL amyloidosis)
by: Salem Bouomrani, et al.
Published: (2021-04-01)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
by: Giovanni Palladini, et al.
Published: (2021-03-01)

LIGHT CHAIN AMYLOIDOSIS
by: Paolo Milani, et al.
Published: (2018-03-01)

Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021
by: M. Hasib Sidiqi, et al.
Published: (2021-05-01)

Light-Chain Cardiac Amyloidosis
by: Gonzalo Barge-Caballero, MD, et al.
Published: (2019-10-01)

How I manage systemic light chain amyloidosis
by: Gregory P. Kaufman, et al.
Published: (2021-09-01)

Racial disparities in patients diagnosed with light chain (AL) amyloidosis
by: Anita D’Souza, et al.
Published: (2021-04-01)

Transthyretin cardiac amyloidosis: an update on diagnosis and treatment
by: Hiroyuki Yamamoto, et al.
Published: (2019-12-01)

Differences in immunoglobulin light chain species found in urinary exosomes in light chain amyloidosis (Al).
by: Marina Ramirez-Alvarado, et al.
Published: (2012-01-01)

Pseudoxanthoma Elasticum and Light-Chain Amyloidosis
by: M. Carlesimo, et al.
Published: (2012-09-01)

DUAL expectations in light chain amyloidosis
by: Stefan Schönland, et al.
Published: (2020-07-01)

Novel Therapies in Light Chain Amyloidosis
by: Paolo Milani, et al.
Published: (2018-05-01)

Localized Lymph Node Light Chain Amyloidosis
by: Binod Dhakal, et al.
Published: (2015-01-01)

Systemic AL Amyloidosis: Current Approaches to Diagnosis and Management
by: Despina Fotiou, et al.
Published: (2020-08-01)

Light chain amyloidosis presenting as retiform purpura
by: Yssra S. Soliman, MD, et al.
Published: (2021-06-01)

A case of systemic light - chain amyloidosis
by: ZHOU Qi, et al.
Published: (2018-03-01)

Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis
by: Kathleen W. Zhang, MD, et al.
Published: (2020-03-01)

Magnetic Resonance Elastography of Liver in Light Chain Amyloidosis
by: Sudhakar K. Venkatesh, et al.
Published: (2019-05-01)

Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis
by: Sadichhya Lohani, et al.
Published: (2016-01-01)

Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
by: Tanya L Poshusta, et al.
Published: (2009-01-01)

Autopsy findings in a patient with primary systemic AL (kappa light chain) amyloidosis
by: Felipe Lourenço Ledesma, et al.
Published: (2021-05-01)

The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
by: Emilia Czyżewska, et al.
Published: (2021-03-01)

Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives
by: Sarosiek S, et al.
Published: (2019-10-01)

Dissecting the Molecular Features of Systemic Light Chain (AL) Amyloidosis: Contributions from Proteomics
by: Paola Rognoni, et al.
Published: (2021-08-01)

A real-world study on diagnosis and prognosis of light-chain cardiac amyloidosis in Southern China
by: Zhijian Wu, et al.
Published: (2021-09-01)

Beyond Andromeda: Improving Therapy for Light Chain Amyloidosis
by: Gregory P. Kaufman, et al.
Published: (2021-02-01)

Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders
by: Rohit R. Rao, et al.
Published: (2016-01-01)

Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
by: Kathleen W. Zhang, MD, et al.
Published: (2019-06-01)

Light-Chain Amyloidosis With Peripheral Neuropathy as an Initial Presentation
by: Min Qian, et al.
Published: (2021-09-01)

Localized Immunoglobulin Light-Chain Amyloidosis of the Ulnar Nerve
by: Shinsuke Morisaki, et al.
Published: (2021-05-01)

Pathogenesis of light chain-induced dysfunction in cardiac amyloidosis
by: Snyder, Christina AnnaMarie
Published: (2016)

A Rare Case of Light Chain Amyloidosis of the Gastrointestinal Tract
by: Kathrin Dvir, et al.
Published: (2020-01-01)

Exploring the sequence features determining amyloidosis in human antibody light chains
by: Puneet Rawat, et al.
Published: (2021-07-01)

Progressive chorioretinal involvement in a patient with light-chain (AL) amyloidosis: a case report
by: Edouard Augstburger, et al.
Published: (2020-02-01)

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis.
by: Surbhi Sidana, et al.
Published: (2017-01-01)

Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced disease
by: Gina Patel, et al.
Published: (2019-03-01)

Monosialoganglioside-Containing Nanoliposomes Restore Endothelial Function Impaired by AL Amyloidosis Light Chain Proteins.
by: Franco, Daniel A, et al.
Published: (2016)

Thermal Stability Threshold for Amyloid Formation in Light Chain Amyloidosis
by: Tanya L. Poshusta, et al.
Published: (2013-11-01)

Multiple myeloma and light-chain amyloidosis: a rare presentation
by: carmenza Liliana Sandoval, et al.
Published: (2018-07-01)

Proteomic Analysis for the Diagnosis of Fibrinogen Aα-chain Amyloidosis
by: Graham W. Taylor, et al.
Published: (2019-07-01)